E STRADIOL FATTY ACID esters are extremely lipophilic metabolites that are formed by the action of acylcoenzyme A (CoA):estradiol acyltransferase. An earlier study from our laboratory indicated that clofibrate and gemfibrozil (peroxisome proliferators and hypolipidemic drugs) are potent inducers of rat liver microsomal acyl-CoA:estradiol acyltransferase (1) . The stimulatory effect of clofibrate administration on fatty acid esterification of estradiol by liver microsomes was paralleled in vivo by enhanced estrogenic activity in the mammary gland, but not in the uterus (2) .
Peroxisome proliferators are a diverse class of compounds that have been widely used, and they are of pharmaceutical, industrial, and environmental importance. Examples of peroxisome proliferators include hypolipidemic drugs, herbicides, plasticizers, and solvents (3, 4) . Administration of peroxisome proliferators to rats and mice results in an increase in the number and size of hepatic peroxisomes and an increase in fatty acid-metabolizing enzymes, such as peroxisomal fatty acyl-CoA oxidase and microsomal fatty acid -hydroxylase (CYP450 4A) (3, 5) . The induction of these enzymes by peroxisome proliferators is known to result from an increased rate of gene transcription mediated by PPAR␣, a member of the steroid hormone receptor superfamily (6, 7) . PPAR␣ mediates the activation of genes through dimerization with retinoid X receptor ␣ and binding to cis-acting regulatory elements (peroxisome proliferator response elements) upstream of promoter regions in target genes (8, 9) . PPAR␣ null mice (Ϫ/Ϫ) lack the expression of PPAR␣ protein (10) . Administration of prototypical peroxisome proliferators, such as clofibrate or Wy-14,643, to PPAR␣ null mice does not result in detectable hepatomegaly, peroxisome proliferation, induction of the mRNA encoding the peroxisomal and microsomal lipid-metabolizing enzymes, or hepatocarcinogenesis (responses that were observed in PPAR␣ wild-type mice) (6, 10) . These results indicate that PPAR␣ is required for mediating the pleiotropic response of rodents to peroxisome proliferators.
In the present study we evaluated the effects of peroxisome proliferators on liver microsomal acyl-CoA:estradiol acyltransferase and acyl-CoA:testosterone acyltransferase in PPAR␣ wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice to determine whether the induction of these enzyme activities is dependent on PPAR␣. 
Materials and Methods

Animals
Female PPAR␣ wild-type mice (ϩ/ϩ) and null mice (Ϫ/Ϫ) on an Sv/129 genetic background were used. In the first experiment PPAR␣ wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice were fed an AIN-76A diet or 0.5% clofibrate (wt/wt) in an AIN-76A diet for 3 wk. Livers were removed for the preparation of microsomes as described previously (11) . In a second experiment female C57 BL/6J mice and female Sprague Dawley rats, purchased from Harlan Sprague Dawley, Inc. (Indianapolis, IN), were fed 0.5% clofibrate diet for 2 wk, and liver microsomes were prepared. In a third experiment PPAR␣ wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice were fed 0.1% Wy-14,643 diet for 11 d. Livers were removed for the preparation of microsomes. Protein concentrations were determined with the Bio-Rad Laboratories, Inc., assay method (Richmond, CA) according to the supplier's instructions, using BSA as a standard.
Enzyme assays
Enzyme assays for the esterification of estradiol or testosterone by rat liver microsomes were carried out as described previously (1). Incubation mixtures consisted of 10 m 3 H-labeled estradiol or testosterone (ϳ1-2 Ci), 100 m oleoyl-CoA, together with 5 mm magnesium chloride in 0.1 m sodium acetate buffer (pH 5.0) in a final volume of 0.2-0.5 ml. For preparation of the incubation mixture, radioactive estradiol or testosterone in ethanol was added first and dried under nitrogen, and then the remaining components of the incubation mixture (including nonradioactive estradiol or testosterone in 2-5 l ethanol) were added. This procedure resulted in uniform distribution of radioactive and nonradioactive steroid throughout the incubation mixture. The reaction was initiated by the addition of hepatic microsomes (0.25-0.5 mg protein/ ml). After incubation at 37 C for 30 min, the reaction was arrested by placing the tubes on ice, followed by addition of ice-cold sodium acetate buffer and ethyl acetate. The samples were vortexed immediately and then centrifuged for 10 min at 3000 ϫ g. The organic upper phase was removed, and the extraction was repeated a second time. The organic solvent extracts were combined and evaporated to dryness under a stream of nitrogen. The resulting residues were dissolved in 100 l methanol and were analyzed by HPLC.
HPLC methods
Measurement of esterified metabolites of estradiol and testosterone was performed on a Spherisorb ODS column (5-m particle size; id, 250 ϫ 4.6 mm). The HPLC system consisted of a Waters 600E solvent gradient programmer (Waters Corp., Milford, MA), a Waters LambdaMax model 481 UV detector (set at 280 nm), and a radioactive flow detector (␤-ram from IN/US, Fairfield, NJ) with a liquid cell (for 3 H detection). The solvent gradient used for elution of the oleoyl ester of estradiol was described previously (1). The solvent system consisted of acetonitrile/H 2 O with 0.1% acetic acid/methanol: 12 min isocratic at 30/6/64, 6 min with a no. 10 convex gradient to 60/0/40, 15 min isocratic at 60/0/40, 2 min with a no. 2 convex gradient to 20/0/80, and 5 min isocratic at 20/0/80, and the column was then returned to initial conditions over 15 min. The mobile phase for elution of the oleoyl ester of testosterone was isocratic 100% methanol for 20 min. The flow rate was 1.2 ml/min. The retention times of the radioactive metabolites agreed exactly with the corresponding UV-absorbing peaks. Incubation of 3 Hlabeled estradiol or testosterone with oleoyl-CoA each resulted in a single radioactive metabolite peak with a retention time of 27.6 or 11.6 min, respectively, with the appropriate HPLC solvent systems described above. Metabolite quantification was based on the amount of radioactivity in the metabolite peak compared with the total radioactivity collected from the HPLC column from each sample.
Statistical analysis
Data are presented as the mean Ϯ sd. Differences between means were assessed using a two-way ANOVA test, Scheffé's test or t test. The two-way ANOVA test and Scheffé's test were carried out using StatView software (Abacus Concepts, Inc., Berkeley, CA).
Results
Species difference in clofibrate-induced increases in liver microsomal acyl-CoA:estradiol acyltransferase activity
Female PPAR␣ wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice were fed 0.5% clofibrate in an AIN-76A diet for 3 wk. Although the liver/body weight ratio in wild-type mice was increased 45% after treatment with clofibrate, the liver/body weight ratio in PPAR␣ null mice was not altered by clofibrate treatment (data not presented). Clofibrate administration did not stimulate liver microsomal acyl-CoA:estradiol acyltransferase activity in wild-type (ϩ/ϩ) or PPAR␣ null (Ϫ/Ϫ) mice (Table 1 ). These results indicate that clofibrate-induced increases in liver size in wild-type mice can be dissociated from clofibrate-induced increases in hepatic acyl-CoA:estradiol acyltransferase activity.
Since our previous studies indicated that clofibrate administration markedly stimulated liver microsomal acylCoA:estradiol acyltransferase activity in rats (1), the results of the above experiment suggested that mice may be less sensitive than rats to induction of acyl-CoA:estradiol acyltransferase by clofibrate. To make a further comparison, female C57BL/6J mice and Sprague Dawley rats were fed 0.5% clofibrate for 2 wk. In C57BL/6J mice, the liver/body weight ratio was increased 36% by the clofibrate treatment (data not presented), and the liver microsomal acyl-CoA:estradiol acyltransferase activity was increased 89% (Table 1) . In Sprague Dawley rats, the liver/body weight ratio was increased 18% (data not presented), but estradiol esterification in liver microsomes was stimulated 900% by the clofibrate treatment ( Table 1) . The results indicate a marked species difference in sensitivity to clofibrate induction of acyl-CoA: estradiol acyltransferase between rats and mice and also a strain difference in inducibility between Sv/129 and C57BL/6J mice. Female PPAR␣ wild-type (ϩ/ϩ) and null (Ϫ/Ϫ) mice were fed 0.5% clofibrate diet for 3 weeks. Female C57BL/6J mice and SpragueDawley rats were fed 0.5% clofibrate diet for 2 weeks. Liver microsomes were incubated with 10 M [ 3 H]estradiol and 100 M oleoylCoA in sodium acetate buffer (pH 5.0) as described in Materials and Methods. The formation of estradiol-oleoyl ester was determined. Each value is the mean Ϯ SD obtained from three to five rats. The numbers in parentheses indicate the percent change in comparison with the control diet group. a P Ͻ 0.05 for the comparison of ϩ/ϩ and Ϫ/Ϫ mice (by two-way ANOVA test).
b P Ͻ 0.05 for the comparison of mice or rats fed control and clofibrate diets (by t test).
Effect of Wy-14,643 administration on the esterification of estradiol and testosterone by liver microsomes from rats and wild-type (ϩ/ϩ) and PPAR␣ null (Ϫ/Ϫ) mice
The observation that administration of 0.5% clofibrate diet stimulated liver microsomal acyl-CoA:estradiol acyltransferase in rats, but not in wild-type (ϩ/ϩ) or PPAR␣ null (Ϫ/Ϫ) mice ( Table 1 ), suggested that these mice are less sensitive to the induction of liver microsomal acyl-CoA: estradiol acyltransferase by clofibrate than rats ( Table 1) . Because of these observations we studied the effect of a more potent peroxisome proliferator, Wy-14,643, on estradiol esterification in rats and in wild-type and PPAR␣ null mice. Feeding 0.1% Wy-14,643 to female rats for 7 d increased the liver microsomal esterification of estradiol by about 5-fold (39.4 Ϯ 4.9 vs. 189.2 Ϯ 33.9 pmol estradiol-oleoyl ester formed/mg protein/min; mean Ϯ sd for three control rats and four treated rats), and the liver microsomal esterification of testosterone was increased about 6-fold (26.5 Ϯ 2.9 vs. 168.6 Ϯ 28.2 pmol testosterone-oleoyl ester formed/mg protein/min; mean Ϯ sd for two control rats and four treated rats).
In another experiment female wild-type (ϩ/ϩ) mice and PPAR␣ null (Ϫ/Ϫ) mice were fed 0.1% Wy-14,643 diet for 11 d. The liver/body weight ratio in wild-type mice was increased about 3-fold by Wy-14,643 administration; in contrast, the liver/body weight ratio in PPAR␣ null mice was not altered by Wy-14,643 administration (data not presented). Liver microsomal formation of the oleoyl ester of estradiol or testosterone was increased 4-to 5-fold in wild-type mice treated with Wy-14,643. In contrast, the liver microsomal esterification of estradiol and testosterone was not stimulated in PPAR␣ null (Ϫ/Ϫ) mice treated with Wy-14,643 (Table 2) .
Discussion
Previous studies from our laboratory indicated that clofibrate and gemfibrozil are potent inducers of rat liver microsomal acyl-CoA:estradiol acyltransferase (1). In the present study, however, we found that administration of 0.5% clofibrate in the AIN-76A diet did not stimulate liver microsomal acyl-CoA:estradiol acyltransferase activity in female PPAR␣ wild-type mice on an Sv/129 background. Liver microsomal acyl-CoA:estradiol acyltransferase activity was stimulated by only 90% in female C57BL/6J mice. In contrast, similar clofibrate administration to female Sprague Dawley rats resulted in increased liver microsomal acyl-CoA:estradiol acyltransferase activity by 900% (Table 1) . These results indicate that sensitivity to induction of liver microsomal acyl-CoA:estradiol acyltransferase by clofibrate is species dependent; mice are less sensitive than rats. Several studies have reported different sensitivities to peroxisome proliferators between mice and rats (12) (13) (14) . The different responses to clofibrate administration of mice and rats observed in this study could be partially explained by different pharmacokinetics or elimination rates of clofibrate in mice and rats. The elimination half-life of clofibric acid (the active form of clofibrate) was 2 h in mice and 5-8 h in rats (15) . Since mice and rats have comparable levels of hepatic PPAR␣ mRNA (16) , the different responses to clofibrate administration in the two species may not be explained by the relative abundance of the PPAR␣. Other possible reasons for the different sensitivities of rat and mouse liver microsomal acyl-CoA:estradiol acyltransferase to induction by clofibrate may include different regulatory mechanisms for the target genes and/or different esterase activities for hydrolyzing the estradiol fatty acid esters in rats and mice.
In another experiment, wild-type and PPAR␣ null mice were treated with Wy-14,643, a more potent peroxisome proliferator (PPAR␣ agonist) than clofibrate. Liver microsomal acyl-CoA:estradiol acyltransferase activity and acylCoA:testosterone acyltransferase activity were 4-to 5-fold higher in wild-type (ϩ/ϩ) mice treated with dietary Wy-14,643, but no increase was observed in PPAR␣ null (Ϫ/Ϫ) mice (Table 2 ). These studies indicate that the induction of liver microsomal esterification of estradiol and testosterone by peroxisome proliferators is dependent on PPAR␣.
The induction of fatty acyl-CoA oxidase and CYP450 4A by peroxisome proliferators is known to result from an increased rate of gene transcription mediated by PPAR␣ (10). Administration of clofibrate or gemfibrozil to rats induces liver microsomal acyl-CoA:estradiol acyltransferase activity without altering its pH optimum or K m value (1). These observations suggest that administration of clofibrate or gemfibrozil increased the level of the same fatty acyl-CoA: estradiol acyltransferase enzyme that is present in microsomes from untreated rats. Further studies are needed to determine whether clofibrate or gemfibrozil administration stimulates transcription of the fatty acyl-CoA:estradiol acyltransferase gene, enhances the stability of the corresponding mRNA, facilitates the translation of the corresponding mRNA, and/or inhibits the breakdown of the fatty acyl-CoA acyltransferase protein.
During the course of our studies, we found that treatment of mice with Wy-14,643 increased the esterification of testosterone (Table 2 ). Unpublished observations in our laboratory indicate that treatment of rats with clofibrate also stimulates the liver microsomal esterification of testosterone, corticosterone, pregnenolone, and dehydroepiandrosterone. The physiological significance of the effect of clofibrate administration to enhance the esterification of several steroid hormones is unknown. Female wild-type (ϩ/ϩ) and PPAR␣ null (Ϫ/Ϫ) mice were fed 0.1% Wy-14,643 for 11 days. Liver microsomes (0.5 mg protein/ml) were incubated with 10 M [ 3 H]estradiol or testosterone and 100 M oleoylCoA in a final volume of 0.2 ml sodium acetate (0.1 M; pH 5.0) at 37 C for 30 min. The formations of estradiol-oleoyl ester and testosteroneoleoyl ester were determined as described in Materials and Methods. Each value is the mean Ϯ SD of microsomes from three mice.
a P Ͻ 0.05 for the comparison between mice fed a control diet and those fed 0.1% Wy-14,643 (by two-way ANOVA and Scheffé's test).
In summary, the results of our studies indicate that the induction of liver microsomal acyl-CoA:estradiol acyltransferase and microsomal acyl-CoA:testosterone acyltransferase activities by a prototypical peroxisome proliferator is dependent on PPAR␣.
